Rare lephants
Screener

Phio Pharmaceuticals Corp.

PHIO ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
8-K May 12, 2022 CURRENT REPORT
10-Q May 12, 2022 FORM 10-Q
8-K May 10, 2022 FORM 8-K
8-K May 2, 2022 FORM 8-K
3 Apr 29, 2022 FORM 3 SUBMISSION
10-K/A Apr 29, 2022 FORM 10-K AMENDMENT 1
8-K Mar 22, 2022 CURRENT REPORT
10-K Mar 22, 2022 FORM 10-K
4 Mar 3, 2022 FORM 4 SUBMISSION
4 Mar 3, 2022 FORM 4 SUBMISSION
8-K Mar 3, 2022 CURRENT REPORT
4 Feb 16, 2022 FORM 4 SUBMISSION
4 Feb 16, 2022 FORM 4 SUBMISSION
4 Feb 16, 2022 FORM 4 SUBMISSION
4 Feb 16, 2022 FORM 4 SUBMISSION
4 Feb 16, 2022 FORM 4 SUBMISSION
4 Feb 16, 2022 FORM 4 SUBMISSION
4 Feb 16, 2022 FORM 4 SUBMISSION
4 Feb 16, 2022 FORM 4 SUBMISSION
SC 13G/A Feb 11, 2022 AMEDMENT NO. 2 TO SCHEDULE 13G
SC 13G/A Jan 20, 2022 PHIO PHARMACEUTICALS CORP.
25-NSE Dec 21, 2021
8-K Nov 10, 2021 FORM 8-K
10-Q Nov 10, 2021 FORM 10-Q
4 Aug 17, 2021 FORM 4 SUBMISSION
← Newer Page 12 of 36 · 892 filings Older →